LAGUNA BEACH, Calif., Dec. 2, 2025 /PRNewswire/ -- Ryght AI, the leading intelligent platform for clinical trial site selection, feasibility, and study operations today announced it will host a ...
NASHVILLE, TENNESSEE / ACCESS Newswire / November 20, 2025 / CenExel, a leading network of clinical research sites, is hosting a two-day Good Clinical Practice (GCP) training initiative beginning ...
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced it will host a ...
Company to Host Key Opinion Leader Event on May 8 at 1:30pm ET to Discuss Updated Results of VERSATILE-002, Unmet Treatment Needs in Advanced Head and Neck Cancer and planned Triple Combination Trial ...
Sarasota Memorial Hospital is part of a clinical trial for a drug that may reduce heart attacks in patients with a specific genetic variant. The investigational drug, dalcetrapib, is being studied for ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ...
Sarasota Memorial Hospital is conducting a clinical trial for a new ovarian cancer drug, Mirvetuximab Soravtansine. The drug targets the protein folate receptor-alpha, often found in high levels in ...
Sarasota Memorial Hospital is enrolling eligible patients in a clinical trial of an investigational drug that could reduce heart attacks and mortality in individuals with a specific genetic variant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback